Skip to main content
. 2021 Aug 3;21:317. doi: 10.1186/s12893-021-01312-1

Fig. 3.

Fig. 3

Plasma levels of TSH, FT3 and FT4 in patients with benign thyroid nodules during follow-up at baseline, 1, 3, 6, and 12 months